Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.42 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.42 |
| ▸ | MGAM | O43451 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | SI | P14410 | 1/20 | 0.41 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.36 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.35 |
| ▸ | PGR | P06401 | 1/20 | 0.35 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.35 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10012012 | 0.81 | ALDH1A1 (0.43) | ALDH1A1HSD17B10TSHR | |
| SCHEMBL10593569 | 0.80 | ALDH1A1 (0.37) | ALDH1A1ALOX15HSD17B10MGAMGAA | |
| SCHEMBL4984393 | 0.78 | MGAM (0.46) | ALDH1A1CYP3A4ALOX15HSD17B10CHRM1 | |
| SCHEMBL22040635 | 0.78 | MGAM (0.46) | ALDH1A1CYP3A4ALOX15HSD17B10CHRM1 | |
| SCHEMBL1245715 | 0.78 | ALDH1A1 (0.50) | ALDH1A1CYP3A4ALOX15HSD17B10CHRM1 | |
| SCHEMBL10011326 | 0.77 | MET (0.35) | ALDH1A1CYP3A4ALOX15HSD17B10CHRM1 | |
| SCHEMBL13136942 | 0.76 | ALDH1A1 (0.53) | ALDH1A1CYP3A4ALOX15HSD17B10CHRM1 | |
| SCHEMBL10979567 | 0.74 | ALDH1A1 (0.44) | ALDH1A1CYP3A4ALOX15HSD17B10CHRM1 | |
| SCHEMBL10010403 | 0.74 | ALDH1A1 (0.44) | ALDH1A1CYP3A4ALOX15HSD17B10CHRM1 | |
| SCHEMBL10012399 | 0.74 | TSHR (0.36) | HSD17B10MGAMGAASIMGAM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12624309-B2 | Enol ether properfume | FIRMENICH SA (CH) | 2026-05-12 | — | — | US | disclosed |
| EP-4139274-B1 | ENOL ETHER PROPERFUME | FIRMENICH & CIE (CH) | 2024-02-14 | — | — | EP | disclosed |
| US-20230220298-A1 | ENOL ETHER PROPERFUME | FIRMENICH & CIE (CH) | 2023-07-13 | — | — | US | disclosed |
| EP-4139274-A1 | ENOL ETHER PROPERFUME | Firmenich SA (CH) | 2023-03-01 | — | — | EP | disclosed |
| CN-115702138-A | Enol ether pro-fragrances | 弗门尼舍有限公司 | 2023-02-14 | — | — | CN | disclosed |
| WO-2021250164-A1 | ENOL ETHER PROPERFUME | FIRMENICH SA (CH) | 2021-12-16 | — | — | WO | disclosed |
| CN-103097387-B | Ring-fused pyrimidines and triazines and use thereof for treating and/or preventing cardiovascular diseases | 拜耳知识产权有限责任公司 | 2016-11-02 | — | — | CN | disclosed |
| US-9130244-B2 | Nonaqueous electrolyte solution and electrochemical element using same | UBE INDUSTRIES, LTD. (JP) | 2015-09-08 | — | — | US | disclosed |
| EP-2908376-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME | Ube Industries, Ltd. (JP) | 2015-08-19 | — | — | EP | disclosed |
| CN-104812762-A | Substituted annulated pyrimidines and triazines, and use thereof | Bayer Pharma AG | 2015-07-29 | — | — | CN | disclosed |
| EP-2479831-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME | Ube Industries, Ltd. (JP) | 2012-07-25 | — | — | EP | disclosed |
| US-20120171581-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME | UBE INDUSTRIES, LTD. (JP) | 2012-07-05 | — | — | US | disclosed |
| CN-101432129-A | Novel compounds that are useful for improving pharmacokinetics | ABBOTT LAB (US) | 2009-05-13 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230220298-A1 | ENOL ETHER PROPERFUME | CYP2E1, ADH5, ECI1 | ALDH1A1 107/4885CYP3A4 28/4885ALOX15 314/4885 |
| US-20120171581-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME | SLC8A1, OR10J3, SLC8B1 | ALDH1A1 2965/4885CYP3A4 3038/4885ALOX15 1722/4885 |
| US-12624309-B2 | Enol ether properfume | CYP2E1, CBR1, ADH5 | ALDH1A1 33/4885CYP3A4 24/4885ALOX15 139/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.